Mirum Pharmaceuticals announces results of 2023 annual meeting of stockholders

Mirum Pharmaceuticals, Inc.

Elected Lon Cardon, William Fairey, and Timothy Walbert as Class I directors to serve until 2026.
Each director received overwhelming support: Cardon 30.6M for, Fairey 30.4M for, Walbert 27.5M for.
Ratified Ernst & Young as independent auditor for FY 2023 with 34.2M votes for, 3.4K against.
Total shares outstanding and entitled to vote: 38,030,661 as of record date April 17, 2023.

item 5.07

Key facts

Extracted from this filing and checked against the source text.

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Mirum Pharmaceuticals, Inc. shareholders approved Election of Directors at the 2023-06-12 meeting.

Proposal: director election
Outcome: passed
Meeting: 2023-06-12

Exact text from the filing

Proposal 1. Election of Directors The Company’s stockholders elected the three persons listed below as Class I directors, each to serve until the Company’s 2026 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The final voting results are as follows: Votes For Votes Withheld Broker Non-Votes Lon Cardon 30,587,478 410,063 3,228,927 William Fairey 30,362,034 635,507 3,228,927 Timothy Walbert 27,482,518 3,515,023 3,228,927

View on SEC.gov

Shareholder Votes SEC 8-K Item 5.07 confidence 0.9

Mirum Pharmaceuticals, Inc. shareholders approved Ratification of the Selection of Independent Registered Public Accounting Firm at the 2023-06-12 meeting.

Proposal: auditor ratification
Outcome: passed
Meeting: 2023-06-12

Exact text from the filing

Proposal 2. Ratification of the Selection of Independent Registered Public Accounting Firm The Company’s stockholders ratified the selection by the Audit Committee of the Company’s Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2023. The final voting results are as follows: Votes For Votes Against Abstentions Broker Non-Votes 34,194,852 3,376 28,240

View on SEC.gov

Browse all shareholder votes →

Mirum Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-166018

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.